CURIS, INC. Long-term Debt, Gross
CURIS, INC. (CRIS) had Long-term Debt, Gross of $28.70 million as of 2018-12-31, per its 10-K filed 2020-03-19.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentCarryingAmount · last filed 2020-03-19
- 2018-12-31: Long-term Debt, Gross $28.70M.
- 2017-12-31: Long-term Debt, Gross $35.80M.
- 2016-12-31: Long-term Debt, Gross $14.99M.
- 2015-12-31: Long-term Debt, Gross $19.63M; Long-term Debt, Gross as first filed $19.63M.
| Period end | Long-term Debt, Gross | Long-term Debt, Gross as first filed |
|---|---|---|
| 2018-12-31 | $28.70M 10-K · filed 2020-03-19 | |
| 2017-12-31 | $35.80M 10-K · filed 2019-03-26 | |
| 2016-12-31 | $14.99M 10-K · filed 2018-03-08 | |
| 2015-12-31 | $19.63M 10-K · filed 2017-03-09 | $19.63M 10-K · filed 2016-02-29 |
| 2014-12-31 | $22.66M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $23.63M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $24.45M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $26.91M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $28.05M 10-K · filed 2015-02-24 | |
| 2013-09-30 | $29.25M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $29.16M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $29.97M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $30.00M 10-K · filed 2014-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |